Lv2
136 积分 2024-03-10 加入
An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies
3天前
已完结
Off-the-shelf CAR T cells for refractory autoimmunity
9天前
已完结
Who wins the combat, CAR or TCR?
3个月前
已完结
Isolation, Culture, and Characterization of Human Umbilical Cord Stroma-derived Mesenchymal Stem Cells
4个月前
已完结
Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1
4个月前
已完结
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
4个月前
已完结
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
4个月前
已完结
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
5个月前
已完结
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
5个月前
已完结
The cryptic role of CXCL17/CXCR8 axis in the pathogenesis of cancers: a review of the latest evidence
6个月前
已完结
Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib, and Abl/Lyn inhibitor INNO-406 in newly established K562 variants with BCR-ABL gene amplification
1年前
已采纳
皖公网安备34019202002308
